- Corporate Officers - M
- Mclaughlin John Peter
Insider Trading History of Mclaughlin John Peter
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Mclaughlin John Peter since 2009.
This trader's CIK number is 1277967.
At the time of last reporting, Mclaughlin John Peter was the Officer of Pdl Biopharma, Inc.. (stock ticker symbol PDLI).
Also see all insider trading activities at Pdl Biopharma, Inc..
Note that in the past
MCLAUGHLIN JOHN PETER also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Pdl Biopharma, Inc. (PDLI) by Mclaughlin John Peter
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | PDLI | 0 | $0 | 327,934 | $855,773 | 0 | $0 |
| 2009 | PDLI | 0 | $0 | 0 | $0 | 28,415 | $153,838 |
Yearly summary of insider trading at Seagen Inc. (SGEN) by Mclaughlin John Peter
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2011 | SGEN | 0 | $0 | 0 | $0 | 25,000 | $245,500 |
Insider trading activities at 2 companies by Mclaughlin John Peter:
1. Pdl Biopharma, Inc. (PDLI)
2. Seagen Inc. (SGEN)
Table 1. Insider trading of Pdl Biopharma, Inc. (PDLI) by Mclaughlin John Peter
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-12-22 | PDLI | Sale | 277,934 | 2.61 | 724,573 |
| 2020-12-21 | PDLI | Sale | 50,000 | 2.62 | 131,200 |
| 2009-09-15 | PDLI | Option Ex | 28,415 | 5.41 | 153,838 |
Table 2. Insider trading of Seagen Inc. (SGEN) by Mclaughlin John Peter
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2011-09-09 | SGEN | Option Ex | 25,000 | 9.82 | 245,500 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Mclaughlin John Peter
(Officer of Pdl Biopharma, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.